You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

stage IIIB, IV, recurrent, and metastatic breast cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Breast Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 Trial in Houston

Recruiting
  • Advanced Breast Carcinoma
  • +17 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 5, 2022

BRCA1 Gene Mutation, BRCA2 Gene Mutation, Locally Advanced Solid Tumor Trial in New Brunswick, New York (Laboratory Biomarker

Recruiting
  • BRCA1 Gene Mutation
  • +19 more
  • Laboratory Biomarker Analysis
  • Pembrolizumab
  • New Brunswick, New Jersey
  • +1 more
Nov 16, 2022

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8

Recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +13 more
  • San Francisco, California
    University of California, San Francisco
Jan 6, 2023

Blood and Tumor Samples From Advanced or Metastatic Estrogen

Active, not recruiting
  • Advanced Breast Carcinoma
  • +8 more
  • Biopsy
  • +2 more
  • Scottsdale, Arizona
  • +2 more
Jan 3, 2023

Locally Advanced Breast Carcinoma, Metastatic Breast Carcinoma, Recurrent Breast Carcinoma Trial in United States (Laboratory

Active, not recruiting
Has Results
  • Locally Advanced Breast Carcinoma
  • +7 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Duarte, California
  • +3 more
Jan 31, 2023

Advanced Differentiated Thyroid Gland Carcinoma, Advanced Head and Neck Carcinoma, Advanced Hepatocellular Carcinoma Trial in

Recruiting
  • Advanced Differentiated Thyroid Gland Carcinoma
  • +102 more
  • Cabozantinib S-malate
  • Nivolumab
  • Chicago, Illinois
  • +2 more
Apr 5, 2022

Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Metastatic Lung Non-Small Cell Carcinoma Trial in Seattle

Terminated
Has Results
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +12 more
  • Laboratory Biomarker Analysis
  • ROR1 CAR-specific Autologous T-Lymphocytes
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 11, 2022

Advanced Malignant Tumor, Castleman Disease, Digestive System Carcinoma Trial in Houston (biological, other, drug)

Active, not recruiting
  • Advanced Malignant Neoplasm
  • +38 more
  • Bevacizumab
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 18, 2022

Stage III Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer Trial in Nashville (Atezolizumab, Cobimetinib,

Terminated
Has Results
  • Stage III Breast Cancer
  • +6 more
  • Nashville, Tennessee
    Vanderbilt-Ingram Cancer Center
Aug 10, 2021

Edema, Erythema, Estrogen Receptor Negative Trial in Houston (Laboratory Biomarker Analysis, Pembrolizumab)

Active, not recruiting
  • Edema
  • +8 more
  • Laboratory Biomarker Analysis
  • Pembrolizumab
  • Houston, Texas
    M D Anderson Cancer Center
Jan 23, 2023

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8

Withdrawn
  • Anatomic Stage III Breast Cancer AJCC v8
  • +11 more
  • (no location specified)
Jan 5, 2023

Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +20 more
  • Neoantigen Peptide Vaccine
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 7, 2022

Male Breast Cancer, Recurrent Melanoma, Stage IV Breast Cancer Trial in Columbus (propranolol HCl, Correlative Studies)

Completed
  • Male Breast Cancer
  • +7 more
  • propranolol hydrochloride
  • Correlative Studies
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Dec 4, 2022

Early Breast Cancer Trial (Ribociclib, Letrozole, Ansastrozole)

Not yet recruiting
  • Early Breast Cancer
  • (no location specified)
Apr 12, 2023

Breast Cancer Stage IV, Breast Cancer Metastatic, Communication Trial in San Pedro Garza Garcia (Communication model)

Not yet recruiting
  • Breast Cancer Stage IV
  • +2 more
  • Communication model
  • San Pedro Garza Garcia, Nuevo Leon, Mexico
    Hospital Zambrano Hellion
Apr 28, 2023

Metastatic Malignant Tumor in the Bone, Stage IV Breast Cancer AJCC v6 and v7, Triple-Negative Breast Carcinoma Trial in

Active, not recruiting
  • Metastatic Malignant Neoplasm in the Bone
  • +2 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Jan 4, 2023

Metastatic Melanoma, Stage IIIB Cutaneous Melanoma AJCC v7, Stage IIIC Cutaneous Melanoma AJCC v7 Trial in Jacksonville (drug,

Active, not recruiting
  • Metastatic Melanoma
  • +3 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Jan 3, 2023

Advanced Breast Adenocarcinoma, Advanced HER2-Negative Breast Carcinoma, Anatomic Stage III Breast Cancer AJCC v8 Trial (Best

Withdrawn
  • Advanced Breast Adenocarcinoma
  • +14 more
  • Best Practice
  • +3 more
  • (no location specified)
Jun 7, 2022

Estrogen Receptor Positive, HER2/Neu Negative, Invasive Breast Carcinoma Trial in Los Angeles (procedure, drug, other)

Terminated
  • Estrogen Receptor Positive
  • +16 more
  • Biopsy of Breast
  • +5 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Sep 22, 2022

Breast Cancer Stage IV Trial in Irvine (Gallium-68)

Recruiting
  • Breast Cancer Stage IV
  • Irvine, California
    Hoag Memorial Hospital Presbyterian
May 26, 2023

Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in

Not yet recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +2 more
  • Cetuximab
  • +2 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Oct 2, 2023

Breast Cancer, ER-positive Breast Cancer, HER2-negative Breast Cancer Trial in Miami (AI+CDK4/6i, SERD+CDK4/6i, mTOR inhibitor +

Not yet recruiting
  • Breast Cancer
  • +3 more
  • Miami, Florida
    University of Miami
Apr 12, 2023

HER2-positive Breast Cancer, Stage III Ovarian Epithelial Cancer, Stage III Ovarian Germ Cell Tumor Trial in Seattle

Active, not recruiting
  • HER2-positive Breast Cancer
  • +8 more
  • pNGVL3-hICD vaccine
  • +6 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Nov 1, 2022

Metastatic Lung Non-Small Cell Carcinoma, Metastatic Lung Small Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma Trial in

Active, not recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +24 more
  • 18F-Fluoromisonidazole
  • +4 more
  • La Jolla, California
  • +15 more
Jan 3, 2023

Caregiver, Malignant Pleural Tumor, Metastatic Thymic Carcinoma Trial in Columbus (Palliative Therapy, Questionnaire

Completed
  • Caregiver
  • +11 more
  • Palliative Therapy
  • Questionnaire Administration
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Aug 11, 2022